Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ATRS [NASD]
Antares Pharma Inc.
Index- P/E- EPS (ttm)-0.13 Insider Own7.89% Shs Outstand126.18M Perf Week8.20%
Market Cap516.08M Forward P/E- EPS next Y-0.04 Insider Trans0.10% Shs Float112.73M Perf Month14.57%
Income-14.76M PEG- EPS next Q-0.03 Inst Own36.89% Short Float9.64% Perf Quarter17.53%
Sales20.24M P/S25.50 EPS this Y-129.24% Inst Trans2.85% Short Ratio11.52 Perf Half Y13.93%
Book/sh0.66 P/B6.20 EPS next Y66.70% ROA-22.43% Target Price5.25 Perf Year35.43%
Cash/sh0.54 P/C7.56 EPS next 5Y- ROE-25.52% 52W Range2.60 - 5.58 Perf YTD7.35%
Dividend- P/FCF- EPS past 5Y0.00% ROI-25.15% 52W High-26.70% Beta0.76
Dividend %- Quick Ratio11.19 Sales past 5Y23.50% Gross Margin52.78% 52W Low57.31% ATR0.13
Employees42 Current Ratio11.30 Sales Q/Q-34.03% Oper. Margin-72.92% RSI (14)65.91 Volatility2.55% 3.55%
OptionableYes Debt/Eq0.00 EPS Q/Q-3654.17% Profit Margin-72.94% Rel Volume1.37 Prev Close4.06
ShortableYes LT Debt/Eq0.00 EarningsMay 08 BMO Payout- Avg Volume943.41K Price4.09
Recom1.30 SMA207.72% SMA5012.55% SMA2006.32% Volume1,295,712 Change0.74%
19-May-13 08:32PM  SmithOnStocks Opines On Stocks: May 19th Edition at Seeking Alpha
17-May-13 06:33PM  3 Most Important Upcoming FDA Decisions of 2013 at Motley Fool
10:59AM  Finding Value in the Medical Products and Device Spaces: An Experienced Portfolio Manager Discusses Investing in Overlooked Health Care Areas Wall Street Transcript
16-May-13 02:01PM  Antares: Reiteration Of My Buy Recommendation at Seeking Alpha
15-May-13 01:04PM  ANTARES PHARMA, INC. Financials EDGAR Online Financials
06:37AM  Contraceptive Ring: Another Under-The-Radar Catalyst For Antares at Seeking Alpha
12-May-13 05:34PM  Earnings Volatility Drives These Healthcare Stocks in a New Direction at Wall St. Cheat Sheet
09-May-13 07:00AM  Antares Pharma to Present at the Bank of America Merrill Lynch 2013 Healthcare Conference Business Wire
08-May-13 05:15PM  Antares Pharma Whiffs on Revenues at Motley Fool
03:40PM  Antares Pharma Management Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha
01:52PM  Antares Q1 Results Unimpressive, but Otrexup Could Be Catalyst at Motley Fool
09:32AM  ANTARES PHARMA, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
09:01AM  Antares Pharma Earnings: Heres Why Investors are Ambivalent Now at Wall St. Cheat Sheet
07:07AM  Q1 2013 Antares Pharma, Inc. Earnings Release - Before Market Open CCBN
07:03AM  InPlay: Antares Pharma reports EPS in-line, misses on revs Briefing.com
07:00AM  Antares Pharma Reports First Quarter 2013 Operating and Financial Results Business Wire
02-May-13 09:29AM  Antares: Challenger Emerging Against 400-Year Old Condom at Seeking Alpha
01-May-13 07:00AM  Antares Pharma to Host First Quarter 2013 Operating and Financial Results Conference Call Business Wire
25-Apr-13 01:40PM  Seizing The Blockbuster Opportunity Buried In Conservative Modeling At Antares Pharma at Seeking Alpha +6.76%
01:39PM  5 Stocks Under $10 Set to Soar at TheStreet
18-Apr-13 09:28AM  Thursday's BioPharma Trade Movers at Seeking Alpha
16-Apr-13 08:33AM  InPlay: Antares Pharma announces the issuance of a new patent on VIBEX Device Platform Briefing.com
08:30AM  Antares Pharma Announces the Issuance of a New Patent on VIBEX Device Platform Business Wire
08-Apr-13 03:53PM  Reviving The Blockbuster Potential Of Libigel For Biosante And Antares Pharma at Seeking Alpha
05-Apr-13 04:06PM  4 Healthcare Stock Stories for Weekend Perusal at Wall St. Cheat Sheet
10:42AM  General Motors Ponders The North Korea Situation and 4 Other Hot Stocks at Wall St. Cheat Sheet
07:31AM  InPlay: Antares Pharma announces notice of allowance for new patent on VIBEX QuickShot Device Briefing.com
07:30AM  Antares Pharma Announces Notice of Allowance for New Patent on VIBEX QuickShot Device Business Wire
03-Apr-13 01:15PM  4 Healthcare Stock Stories for Wednesday Investment Wellness at Wall St. Cheat Sheet
07:30AM  Antares Pharma Announces First Shipment of Commercial VIBEX Auto-Injector Devices to Teva Business Wire
26-Mar-13 04:02PM  A Deep Dive Into Antares Pharma's Buyout Thesis at Seeking Alpha
22-Mar-13 06:23AM  Biorunups: What To Expect In The Next Few Months at Seeking Alpha
21-Mar-13 12:14PM  Antares: A Compelling Long Term Investment at Seeking Alpha
04:47AM  Obagi Medical Products Acquired Wednesday, These Biotechs May Be Next at Seeking Alpha
19-Mar-13 01:04PM  ANTARES PHARMA, INC. Financials EDGAR Online Financials
18-Mar-13 08:20PM  5 Fast Growers for Your Consideration at Motley Fool
14-Mar-13 08:03PM  New Star Analyst Rankings for Antares Pharma, Inc. StarMine
08:33AM  Company News for March 14, 2013 Zacks
13-Mar-13 05:03PM  ANTARES PHARMA, INC. Files SEC form 10-K, Annual Report EDGAR Online
05:02PM  Antares Pharma Increases Sales but Misses Estimates on Earnings at Motley Fool
03:17PM  Antares Pharma, Tree.com Announce Earnings at Forbes
03:05PM  Antares Pharma 4Q loss swells on Otrexup costs AP
11:20AM  Antares Pharma Management Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha
11:06AM  Antares Pharma Earnings: Heres Why Investors are Not Happy Now at Wall St. Cheat Sheet
08:06AM  InPlay: Antares Pharma misses by $0.01, reports revs in-line Briefing.com
07:07AM  Q4 2012 Antares Pharma, Inc. Earnings Release - Before Market Open CCBN
07:00AM  Antares Pharma Reports Fourth Quarter and Full Year 2012 Operating and Financial Results Business Wire
12-Mar-13 05:00PM  Does MannKind Have the Wrong Strategy? at Motley Fool
03:10PM  Companies reporting Before the Market Open on Wednesday, March 13 theflyonthewall.com
11-Mar-13 08:57AM  3 Undiscovered Biotech Companies For The Healthcare Investor at Seeking Alpha
10-Mar-13 07:30PM  Antares Pharma Earnings: An Early Look at Motley Fool
06-Mar-13 07:40AM  Zacks Rank #5 Additions for Wednesday Zacks
07:00AM  Antares Pharma to Host Fourth Quarter 2012 Call Business Wire
05-Mar-13 01:14PM  This Metric Says You're Smart to Own Antares Pharma at Motley Fool
04-Mar-13 04:39AM  Zacks Rank #5 Additions for Monday Zacks
27-Feb-13 12:18PM  FDA accepts Antares treatment Otrexup for review AP +5.04%
07:33AM  Antares Pharma'a Otrexup NDA accepted by FDA at theflyonthewall.com
07:30AM  InPlay: Antares Pharma announces FDA acceptance of New Drug Application for OTREXUP Briefing.com
07:30AM  Antares Pharma Announces FDA Acceptance of New Drug Application for OTREXUP Business Wire
26-Feb-13 02:32PM  Roundtable: 5 Disruptive Technologies Leading the Next Medical Revolution at Motley Fool
07:00AM  Antares Pharma to Present at the Cowen and Company 33rd Annual Healthcare Conference Business Wire
06:17AM  Following Crashing Biotechs - 5 Bargains To Consider at Seeking Alpha
25-Feb-13 05:12AM  Zacks Rank #5 Additions for Monday Zacks
21-Feb-13 05:55AM  Recognizing Leadership In Biotech: A Critical Facet Of The Diligence Process at Seeking Alpha
20-Feb-13 11:57AM  Zacks Rank #5 Additions for Wednesday Zacks
07:00AM  Antares Pharma to Participate in the 2013 RBC Capital Markets Healthcare Conference Business Wire
13-Feb-13 07:45AM  Upcoming NDA, Potential Partner Add Further Investment Value For Pozen at Seeking Alpha
07-Feb-13 09:01AM  Zacks Rank #5 Additions for Thursday Zacks
29-Jan-13 10:02AM  5 Superball Stocks at Motley Fool
25-Jan-13 05:14PM  Antares Pharma Turns More Into Less at Motley Fool
24-Jan-13 08:20AM  Record Levels of Available Cash and Moderate R&D Development Will See Big Pharma M&A Activity Increase in 2013 Marketwire
17-Jan-13 06:00AM  'Mad Money' Lightning Round: Cisco Is Good at TheStreet
05:01AM  Cramer's Lightning Round - Cisco Should Be Fine (1/16/13) at Seeking Alpha
03:31AM  Savvy Investors Discover Antares' Growing Revenue Stream at Seeking Alpha
16-Jan-13 06:40PM  [video] Lightning Round at CNBC
06:38PM  Lightning Round: Total SA, Cisco & More at CNBC
11-Jan-13 08:27AM  Antares Rallies Quickly And Confidently On Newest Developments at Seeking Alpha
08:24AM  Zacks #5 Rank Additions for Friday Zacks
10-Jan-13 10:56AM  What's on the Way for Antares Pharma at Motley Fool
09-Jan-13 12:47PM  Why Is Antares Rising So Quickly? at Seeking Alpha +6.44%
08-Jan-13 10:40AM  Legendary Investor Icahn Still Slugging Away With Enzon Pharma at Seeking Alpha
07-Jan-13 02:32PM  Why Growth Stock Antares Is Moving Higher at Seeking Alpha
06-Jan-13 10:34AM  Buy, Sell, or Hold: Arena Pharmaceuticals at Motley Fool
04-Jan-13 01:12PM  Can Antares' Products Power Your Portfolio in 2013? at Motley Fool
01:10PM  Zacks #5 Rank Additions for Friday Zacks
28-Dec-12 08:39AM  Zacks #5 Rank Additions for Friday Zacks
20-Dec-12 10:54AM  This Just In: Upgrades and Downgrades at Motley Fool
10:11AM  On The Fly: Analyst Initiation Summary theflyonthewall.com
08:59AM  Zacks #5 Rank Additions for Thursday Zacks
19-Dec-12 10:10AM  On The Fly: Analyst Initiation Summary theflyonthewall.com
18-Dec-12 07:55AM  Strong Small Cap Biopharma Catalyst Trades And Investments For Consideration at Seeking Alpha
17-Dec-12 09:33AM  InPlay from Briefing.com Briefing.com
09:25AM  InPlay from Briefing.com Briefing.com
09:01AM  InPlay: Antares Pharma submits New Drug Application for OTREXUP Briefing.com
09:00AM  Antares Pharma Announces Submission of New Drug Application for OTREXUP Business Wire
04:51AM  Zacks #5 Rank Additions for Monday Zacks
15-Dec-12 09:32PM  Buy, Sell, or Hold: Affymax at Motley Fool
12-Dec-12 07:58AM  Zacks #5 Rank Additions for Wednesday Zacks
07-Dec-12 06:31PM  Unlocking Antares' Vision For Arthritis Patients at Seeking Alpha
05-Dec-12 08:16AM  Zacks #5 Rank Additions for Wednesday Zacks
Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies, and topical gel-based medicines worldwide. The company's products include Tjet/Zomajet, the needle-free auto injectors to deliver human growth hormone treatment to children without the use of a needle; twin-jector EZ II needle free injectors; Medi-Jet auto injectors; Elestrin, an estrogen replacement gel for the treatment of hot flashes; and Gelnique 3%, an oxybutynin gel product for the treatment of overactive bladder. The company is also developing OTREXUP, a product for the delivery of methotrexate using Medi-Jet technology for the treatment of rheumatoid arthritis, poly-articular-course juvenile rheumatoid arthritis, and psoriasis; and VIBEX QS T, an auto injector for the treatment of testosterone deficiency or replacement therapy. In addition, it is developing Vibex auto injectors; disposable pen injectors; and Nestragel, a contraceptive gel. Antares Pharma, Inc. has collaborative and license agreements with Ferring Pharmaceuticals BV; Teva Pharmaceutical Industries, Ltd.; JCR Pharmaceuticals Co., Ltd.; Actavis, Inc.; Daewoong Pharmaceuticals; BioSante Pharmaceuticals, Inc.; Meda Pharmaceuticals; Population Council; and Pfizer Inc. The company was founded in 1979 and is headquartered in Ewing, New Jersey.